Member Info for CooperD

Nice steady stream of buys this morning.

Morning all o/

Whistler, yeah we've been getting some attention here and we have been building a great base.

Truro,

there is no one test that will make the rest obsolete and in the same breath nor will any test out there obstruct us from having a market share providing there remains a need for testing. All indicators are testing is of the utmost importance now and will be in the future.

I have faith that Lynn Rees knows what he is doing, knows where the competition lies and knows the area he wants to target.

The news today was first class, lets enjoy that.

Two late trades showing up 275k and 150k both look like buys.

Pacman,

worth sticking in here :)

Brokers at US financial and banking group Stifel welcomed today’s “highly encouraging” announcement, reitering their ‘buy’ call on the company’s stock.
A Stifel statement said: “Previous updates from Yourgene have indicated that this announced COVID-19 work was under way, and we believe these are logical and encouraging developments which leverage off the company’s existing expertise and technology platforms.
“We believe that the need and demand for COVID-19 testing is likely to continue to increase in the coming months, as the UK and other countries continue to scale up their testing capacities, and be able to deliver genuine contact tracing and testing.
“We have not changed our forecasts for now, but clearly there could be significant upside on successful execution of these COVID-19 testing plans.”

Volume of trades over 5 mill so we're working through it slowly but surely.

Looking good and with so much more news to come too. Smacking my lips at the prospect.

Jadam,

Yeah, todays share price matters not as it will re-rate when it's ready. I never invested for a quick burst up as I have a target much higher than todays share price.

Looking on yourgene twitter feed and updated website give an insight to where we are headed.

I very pleased with it all.

Yes, bakky and also repeat. I think events, private healthcare, sports, business etc will all be targeted.

Private testing is the aim and will be a great addition to our range of products.

(Sharecast News) - Molecular diagnostics group Yourgene Health has expanded its laboratory capabilities to offer Covid-19 testing services and also begun developing its own test kit for the coronavirus.
Yourgene's testing laboratories will support private testing demand as UK GP surgeries, private clinics and other corporate clients struggle to keep up.

The AIM-listed firm said it was also developing its first infectious disease test called Clarigene SARS-CoV-2 test - a molecular Covid-19 assay, which was able to detect whether individuals were currently infected.

Yourgene aims to release a "Research Use Only" version of Clarigene by the end of June 2020.

Chief executive Lyn Rees said: "The addition of the Clarigene infectious disease product portfolio strengthens our offering through our commercial channels and supports one of the strategic pillars of growth - our product diversification strategy."

Yourgene added that its core molecular diagnostics business was performing in line with management's expectations and remained on track to build on its "strong" year-end performance.

Pacman,

yes, 100% agree. There's not many shares you can rest easy on and this is one of the best on aim in that respect. You just no at some point soon this will re-rate and people will look back and say all the signs were there and they wish they had acted.

Lots of positives in todays news and lots more to come.

More than happy.

twix,

I disagree, my take is todays news is good news and wasn't painted as anything other than good news.

The vaccine if and when it arrives doesn't change that. If we can take todays news at face value the company has released a very positive statement and to go looking for negatives is nit picking at best. There was enough of an update in todays news to give holders a reason to hold and accumulate and I fail to see why this board appears to be so keen to play the positive news down.

The other news items you mentioned will be here shortly as stated. I don't see any point holding the company to deadlines when they have clearly been flat out trying to keep going at full tilt during a pandemic. We have faired very well in comparison to most during these times.

It's a good news day and we should embrace it.

I doubt many will be willing to get a vaccine that was rushed through. I also doubt many will want a vaccine at all, rushed or not.

Regardless, testing is going to be required in any case and will be another income stream for YGEN which is the important thing here.

Yourgene will announce results for the year ended 31 March 2020 by mid-July and will provide details of the confirmed date in due course.

I look forward to the full year results.

Just around the corner. That's enough for me!!

our product diversification strategy. It's also especially pleasing to see that the main growth drivers of the business remain on track and with approval for our new Illumina platform NIPT just around the corner I look forward to providing further updates on our exciting new product development pipeline."

Ray,

thank god for your positivity. A great RNS and I'm more than happy with what RL had to say.

Todays news is great imo.

Twix,

the CE has been recommended for approval and is in the final stages of approval. We more or less have announced it today.

The core molecular diagnostics business continues to perform in line with management expectations and remains on track to build on the strong year end performance announced in the trading update for the year ended 31 March 2020. The Company remains confident of receiving CE marking for its Illumina-based IONA® test in the near future and has been informed that the product has now been recommended for approval and is in the final stages of evaluation.

absolute no brainer and a job well done by LR. We will do very well from this and again, it's only a side note to the BAU.

pacman

Yourgene already has over 300 laboratory customers and a growing global network of distribution channels in place through which to drive sales of the new Clarigene infectious disease portfolio of products. In addition, the test will be run in the Yourgene service laboratory once it is launched as a CE IVD kit.

Notaflipper

Good post and I would rather be here than GDR. GDR was 7p and now £1.45. I think I can see why James is so vociferous. He's worried people might jump ship and come to YGEN for the huge growth.

YGEN has all the growth in front of it and has world class business and products in huge demand and GDR has a test which is priced in now and a bit of a one trick pony.

Or he bough in on the spike to £3 before the done the placing lol

Ygen has all the growth to come is what I would say!